# Finward Bancorp: financial statements, quarterly

FNWD · Nasdaq · CIK 919864 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnwd.md) · [Financials](/companies/fnwd/financials.md) · [Filings](/companies/fnwd/filings.md) · [Insiders](/companies/fnwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [8.6](/filings/0001437749-23-031287.md) | [9.5 d](/filings/0001437749-24-009816.md) | [10.2](/filings/0001437749-24-017039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.4)](/filings/0001437749-24-035334.md) | [(0.4) d](/filings/0001437749-25-010182.md) | [1.0](/filings/0001437749-25-017176.md) | [(0.0)](/filings/0001628280-25-040138.md) | [(0.2)](/filings/0001628280-25-051584.md) | [0.6 d](/filings/0001628280-26-021073.md) | [0.2](/filings/0001628280-26-034588.md) | [(0.0)](/filings/0001628280-26-056715.md) | [0.1](/filings/0001628280-25-051584.md) | [(0.2) d](/filings/0001628280-26-021073.md) | [0.4](/filings/0001628280-26-034588.md) | [0.4](/filings/0001628280-26-056715.md) |
| Net income | $m | [2.2](/filings/0001437749-24-035334.md) | [1.5 d](/filings/0001437749-25-010182.md) | [9.3](/filings/0001437749-25-017176.md) | [0.1](/filings/0001628280-25-040138.md) | [0.6](/filings/0001628280-25-051584.md) | [2.1 d](/filings/0001628280-26-021073.md) | [0.5](/filings/0001628280-26-034588.md) | [2.2](/filings/0001628280-26-056715.md) | [3.5](/filings/0001628280-25-051584.md) | [2.0 d](/filings/0001628280-26-021073.md) | [2.2](/filings/0001628280-26-034588.md) | [2.1](/filings/0001628280-26-056715.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001437749-24-035334.md) | not reported | [2.17](/filings/0001437749-25-017176.md) | [0.03](/filings/0001628280-25-040138.md) | [0.14](/filings/0001628280-25-051584.md) | not reported | [0.11](/filings/0001628280-26-034588.md) | [0.50](/filings/0001628280-26-056715.md) | [0.81](/filings/0001628280-25-051584.md) | not reported | [0.52](/filings/0001628280-26-034588.md) | [0.48](/filings/0001628280-26-056715.md) |
| Basic EPS | $ per share | [0.52](/filings/0001437749-24-035334.md) | not reported | [2.18](/filings/0001437749-25-017176.md) | [0.03](/filings/0001628280-25-040138.md) | [0.14](/filings/0001628280-25-051584.md) | not reported | [0.11](/filings/0001628280-26-034588.md) | [0.50](/filings/0001628280-26-056715.md) | [0.82](/filings/0001628280-25-051584.md) | not reported | [0.52](/filings/0001628280-26-034588.md) | [0.49](/filings/0001628280-26-056715.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,087](/filings/0001437749-23-031287.md) | [2,108](/filings/0001437749-25-010182.md) | [2,072](/filings/0001437749-24-017039.md) | [2,077](/filings/0001437749-24-026776.md) | [2,075](/filings/0001437749-24-035334.md) | [2,061](/filings/0001628280-26-021073.md) | [2,040](/filings/0001437749-25-017176.md) | [2,058](/filings/0001628280-25-040138.md) | [2,053](/filings/0001628280-25-051584.md) | [2,021](/filings/0001628280-26-056715.md) | [2,015](/filings/0001628280-26-034588.md) | [2,041](/filings/0001628280-26-056715.md) |
| Total liabilities | $m | [1,968](/filings/0001437749-23-031287.md) | [1,961](/filings/0001437749-25-010182.md) | [1,920](/filings/0001437749-24-017039.md) | [1,928](/filings/0001437749-24-026776.md) | [1,915](/filings/0001437749-24-035334.md) | [1,909](/filings/0001628280-26-021073.md) | [1,888](/filings/0001437749-25-017176.md) | [1,904](/filings/0001628280-25-040138.md) | [1,887](/filings/0001628280-25-051584.md) | [1,847](/filings/0001628280-26-056715.md) | [1,843](/filings/0001628280-26-034588.md) | [1,862](/filings/0001628280-26-056715.md) |
| Shareholders' equity | $m | [119](/filings/0001437749-24-035334.md) | [136](/filings/0001437749-24-009816.md) | [152](/filings/0001628280-25-040138.md) | [149](/filings/0001628280-25-051584.md) | [160](/filings/0001628280-25-051584.md) | [151](/filings/0001628280-26-056715.md) | [152](/filings/0001628280-26-056715.md) | [154](/filings/0001628280-26-056715.md) | [165](/filings/0001628280-25-051584.md) | [175](/filings/0001628280-26-056715.md) | [172](/filings/0001628280-26-056715.md) | [178](/filings/0001628280-26-056715.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.2 d](/filings/0001437749-24-035334.md) | [1.8 d](/filings/0001437749-25-010182.md) | [(0.0)](/filings/0001437749-25-017176.md) | [2.8 d](/filings/0001628280-25-040138.md) | [(3.7) d](/filings/0001628280-25-051584.md) | [10.8 d](/filings/0001628280-26-021073.md) | [(3.8)](/filings/0001628280-26-034588.md) | [4.8 d](/filings/0001628280-26-056715.md) | [1.2 d](/filings/0001628280-25-051584.md) | [7.7 d](/filings/0001628280-26-021073.md) | [3.6](/filings/0001628280-26-034588.md) | [4.7 d](/filings/0001628280-26-056715.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001437749-24-035334.md) | [0.4 d](/filings/0001437749-25-010182.md) | [0.7](/filings/0001437749-25-017176.md) | [1.6 d](/filings/0001628280-25-040138.md) | [0.5 d](/filings/0001628280-25-051584.md) | [0.2 d](/filings/0001628280-26-021073.md) | [0.2](/filings/0001628280-26-034588.md) | [0.3 d](/filings/0001628280-26-056715.md) | [0.2 d](/filings/0001628280-25-051584.md) | [0.2 d](/filings/0001628280-26-021073.md) | [0.1](/filings/0001628280-26-034588.md) | [0.2 d](/filings/0001628280-26-056715.md) |
| Dividends paid | $m | [1.3 d](/filings/0001437749-24-035334.md) | [1.3 d](/filings/0001437749-25-010182.md) | [0.5](/filings/0001437749-25-017176.md) | [0.5 d](/filings/0001628280-25-040138.md) | [0.5 d](/filings/0001628280-25-051584.md) | [0.5 d](/filings/0001628280-26-021073.md) | [0.5](/filings/0001628280-26-034588.md) | [0.0 d](/filings/0001628280-26-056715.md) | [0.5 d](/filings/0001628280-25-051584.md) | [0.5 d](/filings/0001628280-26-021073.md) | [0.5](/filings/0001628280-26-034588.md) | [0.5 d](/filings/0001628280-26-056715.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,261](/filings/0001437749-23-031287.md) | [4,354](/filings/0001437749-24-017039.md) | [4,259](/filings/0001437749-24-026776.md) | [4,261](/filings/0001437749-24-035334.md) | [4,271](/filings/0001437749-25-017176.md) | [4,271](/filings/0001628280-25-040138.md) | [4,281](/filings/0001628280-25-051584.md) | [4,284](/filings/0001628280-26-034588.md) | [4,296](/filings/0001628280-26-056715.md) | [4,299](/filings/0001628280-25-051584.md) | [4,302](/filings/0001628280-26-034588.md) | [4,319](/filings/0001628280-26-056715.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,333,002 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056715.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.